26.32 +0.55 (2.10%)
REGN
Stock Details
Last Trade:26.32 Change:+0.55 (2.10%) Prev Close:25.77 Open: 26.15 Days Range:25.80 – 26.73 52 Week Range: 11.81 - 28.66 Volume:339276 P/E: N/AEPS:-0.82
View AllRecent Alerts 02/09/10
Recent Alert on 02/03/10 at 12:05pm
Credit Suisse Maintains an 'Outperform' on Regeneron (REGN); Removes From Focus List
Credit Suisse Maintains an 'Outperform' on Regeneron (REGN); Removes From Focus List
Credit Suisse maintains an Outperform rating on Regeneron (Nasdaq: REGN), removes from U.S Focus List. Price target $32. To see all the upgrades/downgrades on shares of REGN, visit our Analyst Ratings page. Regeneron Pharmaceuticals, Inc.... Read More
Recent Alert on 01/11/10 at 8:21am
BioCentury Publishes BioTech Picks for FY10 (HGSI, VRTX, AMGN, More...)
BioCentury Publishes BioTech Picks for FY10 (HGSI, VRTX, AMGN, More...)
Recent Alert on 01/07/10 at 7:53am
Roth Capital Initiates Coverage on Biotechnology and Drugs Stocks
Roth Capital Initiates Coverage on Biotechnology and Drugs Stocks
Recent Alert on 12/04/09 at 7:01am
BioMed Realty (BMR) To Lease 131K Sq. Ft. From Regeneron Pharma (REGN)
BioMed Realty (BMR) To Lease 131K Sq. Ft. From Regeneron Pharma (REGN)
Recent Alert on 11/11/09 at 1:34pm
Merriman Curhan Ford Reiterates a 'Buy' on Regeneron (REGN); Raising Target Range
Merriman Curhan Ford Reiterates a 'Buy' on Regeneron (REGN); Raising Target Range
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
SEC Filing on 02/05/10 at 4:27pm
Form 4 REGENERON PHARMACEUTICAL For: Feb 03 Filed by: GOLDBERG MURRAY A
Form 4 REGENERON PHARMACEUTICAL For: Feb 03 Filed by: GOLDBERG MURRAY A
View AllRecent Blog Posts
Blog Posts on 11/15/09 at 10:50am
Sanofi-Aventis to Establish Venture Capital Fund, Looking for 'Right Brain Activity'
Sanofi-Aventis to Establish Venture Capital Fund, Looking for 'Right Brain Activity'